The FDA on Friday approved Medtronic's Resolute Integrity drug-eluting stent, designed to treat coronary artery disease in patients with diabetes.
FDA approves stent to address CAD in diabetes patients
SmartBrief Job Listings for Health Care
|Compliance and Ethics Director||
Sysmex America, Inc.
|Director, Site Quality Management||
|Palm Springs, CA|
|Compliance Officer-Medical Products||
W. L. Gore